Literature DB >> 6244322

Lack of modulation of pituitary hormone stress response by neural pathways involving opiate receptors.

I J Spiler, M E Molitch.   

Abstract

To evaluate the role of the opiate-like peptidergic pathways in modulating the pituitary hormone response to stress, we measured the GH, PRL, and cortisol responses to hypoglycemia and exercise in normal subjects with and without pretreatment with naloxone, given in the centrally active dose of 0.4 mg iv. Basal serum levels of GH, PRL, and cortisol were not changed significantly by prior naloxone administration. The maximum incremental response of GH to exercise was significantly blunted (13.1 +/- 1.6 vs. 6.0 +/- 1.4; P less than 0.001) by prior naloxone administration. Pretreatment with naloxone did not affect the responses of GH, PRL, or cortisol to hypoglycemia or the PRL response to L-dopa. On the basis of these studies we conclude that the opiate-like peptidergic pathways are not important in the regulation of basal levels of GH, PRL, and cortisol and have only a modest modulating influence on the stress-induced release of the hormones, which may be obscured in the face of severe stress.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6244322     DOI: 10.1210/jcem-50-3-516

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  9 in total

1.  Gonadal steroids do not affect basal growth hormone response to naloxone in humans.

Authors:  P Monteleone; M Maj; M Iovino; L Fiorenza; P M Fiumani; L Steardo
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

2.  Evidence for a GABAergic control of the exercise-induced rise in GH in man.

Authors:  L Steardo; M Iovino; P Monteleone; M Agrusta; F Orio
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

3.  Naloxone increases the response of growth hormone and prolactin to stimuli in obese humans.

Authors:  G Plewe; U Schneider; U Krause; J Beyer
Journal:  J Endocrinol Invest       Date:  1987-04       Impact factor: 4.256

4.  Endorphins and exercise.

Authors:  V J Harber; J R Sutton
Journal:  Sports Med       Date:  1984 Mar-Apr       Impact factor: 11.136

5.  Effects of naloxone on prolactin, growth hormone and cortisol response to insulin hypoglycemia in obese subjects.

Authors:  D Papalia; M Lunetta; M Di Mauro
Journal:  J Endocrinol Invest       Date:  1989-12       Impact factor: 4.256

6.  Hormonal responses to opioid receptor blockade: during rest and exercise in cold and hot environments.

Authors:  David W Armstrong; Bradley D Hatfield
Journal:  Eur J Appl Physiol       Date:  2006-02-09       Impact factor: 3.078

7.  Influence of low doses of naloxone on pituitary secretion in man.

Authors:  E Rolandi; A Marabini; G Magnani; A Sannia; T Barreca
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

8.  The effect of glucose dynamics on plasma copeptin levels upon glucagon, arginine, and macimorelin stimulation in healthy adults : Data from: Glucacop, Macicop, and CARGO study.

Authors:  Cihan Atila; Sophie Monnerat; Sandrine Andrea Urwyler; Julie Refardt; Bettina Winzeler; Mirjam Christ-Crain
Journal:  Pituitary       Date:  2022-06-20       Impact factor: 3.599

9.  Effect of naloxone on counter insulin hormone secretion in insulin-induced hypoglycemia.

Authors:  Y S Ju; S W Kim; I M Yang; J W Kim; Y S Kim; Y K Choi
Journal:  Korean J Intern Med       Date:  1987-07       Impact factor: 2.884

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.